Suppression of Clostridium difficile in the gastrointestinal tracts of germfree mice inoculated with a murine isolate from the family Lachnospiraceae

Infection and Immunity

Volumn 80, Issue 11, 2012, Pages 3786-3794

  Reeves, Angela E ^a   Koenigsknecht, Mark J ^b   Bergin, Ingrid L ^a   Young, Vincent B ^a,b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFOPERAZONE; PROBIOTIC AGENT; RNA 16S;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM ISOLATE; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; CONTROLLED STUDY; DISEASE SEVERITY; ESCHERICHIA COLI; GASTROINTESTINAL TRACT; HISTOPATHOLOGY; LACHNOSPIRACEAE; MORTALITY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENETIC TREE; PRIORITY JOURNAL; SURVIVAL RATE;

ANIMALS; CLOSTRIDIUM DIFFICILE; COLONY COUNT, MICROBIAL; ESCHERICHIA COLI; GASTROINTESTINAL TRACT; GERM-FREE LIFE; GRAM-POSITIVE ENDOSPORE-FORMING RODS; METAGENOME; MICE; MICE, INBRED C57BL; PHYLOGENY; RNA, RIBOSOMAL, 16S;

EID: 84867615958     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00647-12     Document Type: Article

References (46)

1. Barcenilla A, et al. 2000. Phylogenetic relationships of butyrateproducing bacteria from the human gut. Appl. Environ. Microbiol. 66: 1654-1661.
2. Bartlett JG. 2010. Clostridium difficile: progress and challenges. Ann. N. Y. Acad. Sci. 1213:62-69.
3. Bartlett JG, Onderdonk AB, Cisneros RL, Kasper DL. 1977. Clindamycin-associated colitis due to a toxin-producing species of Clostridium in hamsters. J. Infect. Dis. 136:701-705.
4. Britton RA, Young VB. 2012. Interaction between the intestinal microbiota and host in Clostridium difficile colonization resistance. Trends Microbiol. 20:313-319.
5. Chen X, et al. 2008. A mouse model of Clostridium difficile-associated disease. Gastroenterology 135:1984-1992.
6. Collins MD, et al. 1994. The phylogeny of the genus Clostridium: proposal of five new genera and eleven new species combinations. Int. J. Syst. Bacteriol. 44:812-826.
7. Corthier G, Dubos F, Raibaud P. 1985. Modulation of cytotoxin production by Clostridium difficile in the intestinal tracts of gnotobiotic mice inoculated with various human intestinal bacteria. Appl. Environ. Microbiol. 49:250-252.
8. Cotta M, Forster R. 2006. The family Lachnospiraceae, including the genera Butyrivibrio, Lachnospira and Rosburia. Prokaryotes 4:1002-1021.
9. Dubberke E. 2012. Clostridium difficile infection: the scope of the problem. J. Hosp. Med. 7(Suppl. 3):S1-4.
10. Duncan SH, Louis P, Flint HJ. 2007. Cultivable bacterial diversity from the human colon. Lett. Appl. Microbiol. 44:343-350.
11. Falk PG, Hooper LV, Midtvedt T, Gordon JI. 1998. Creating and maintaining the gastrointestinal ecosystem: what we know and need to know from gnotobiology. Microbiol. Mol. Biol. Rev. 62:1157-1170.
12. Fekety R, Silva J, Browne RA, Rifkin GD, Ebright JR. 1979. Clindamycin-induced colitis. Am. J. Clin. Nutr. 32:244-250.
13. Finegold SM, et al. 2005. Clostridium clostridioforme: a mixture of three clinically important species. Eur. J. Clin. Microbiol. Infect. Dis. 24:319-324.
14. Frank DN, et al. 2011. Disease phenotype and genotype are associated with shifts in intestinal-associated microbiota in inflammatory bowel diseases. Inflamm. Bowel Dis. 17:179-184.
15. Frank DN, et al. 2007. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc. Natl. Acad. Sci. U. S. A. 104:13780-13785.
16. Freter R, Ozawa A. 1963. Explanation for limitation of populations of Escherichia coli in broth cultures. J. Bacteriol. 86:904-910.
17. Gorbach SL, Barza M, Giuliano M, Jacobus NV. 1988. Colonization resistance of the human intestinal microflora: testing the hypothesis in normal volunteers. Eur. J. Clin. Microbiol. Infect. Dis. 7:98-102.
18. Hall I, O'Toole E. 1935. Intestinal flora in newborn infants with the description of a new anaerobic pathogen, Bacillus difficilus. Am. J. Dis. Child. 49:390-402.
19. Hedberg ME, et al. Lachnoanaerobaculum a new genus in Lachnospiraceae; characterization of Lachnoanaerobaculum umeaense gen. nov., sp. nov., isolated from human small intestine, Lachnoanaerobaculum orale gen. nov., sp. nov., isolated from saliva and reclassification of Eubacterium saburreum (Prevot) Holdeman and Moore 1970 as Lachnoanaerobaculum saburreum comb. nov. Int. J. Syst. Evol. Microbiol., in press.
20. Hopkins MJ, Macfarlane GT. 2003. Nondigestible oligosaccharides enhance bacterial colonization resistance against Clostridium difficile in vitro. Appl. Environ. Microbiol. 69:1920-1927.
21. Itoh K, Lee WK, Kawamura H, Mitsuoka T, Magaribuchi T. 1987. Intestinal bacteria antagonistic to Clostridium difficile in mice. Lab. Anim. 21:20-25.
22. Kelly CP, et al. 1994. Neutrophil recruitment in Clostridium difficile toxin A enteritis in the rabbit. J. Clin. Invest. 93:1257-1265.
23. Khanna S, Pardi DS. 2010. The growing incidence and severity of Clostridium difficile infection in inpatient and outpatient settings. Expert Rev. Gastroenterol. Hepatol. 4:409-416.
24. Louis P, Flint HJ. 2009. Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine. FEMS Microbiol. Lett. 294:1-8.
25. Manichanh C, Rigottier-Gois L, and, BE. 2006. Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut 55:205-211.
26. May T, Mackie RI, Fahey GC, Jr, Cremin JC, Garleb KA. 1994. Effect of fiber source on short-chain fatty acid production and on the growth and toxin production by Clostridium difficile. Scand. J. Gastroenterol. 29:916-922.
27. Naaber P, et al. 2004. Inhibition of Clostridium difficile strains by intestinal Lactobacillus species. J. Med. Microbiol. 53:551-554.
28. Powell N, SE Jung, B Krishnan. 2008. Clostridium difficile infection and inflammatory bowel disease: a marker for disease extent? Gut 57:1183-1184. (Author reply, 57:1184.).
29. Pryde SE, Duncan SH, Hold GL, Stewart CS, Flint HJ. 2002. The microbiology of butyrate formation in the human colon. FEMS Microbiol. Lett. 217:133-139.
30. Reeves AE, et al. 2011. The interplay between microbiome dynamics and pathogen dynamics in a murine model of Clostridium difficile infection. Gut Microbes 2:145-158.
31. Rolfe RD. 1984. Role of volatile fatty acids in colonization resistance to Clostridium difficile. Infect. Immun. 45:185-191.
32. Rousseau C, et al. 2011. Clostridium difficile colonization in early infancy is accompanied by changes in intestinal microbiota composition. J. Clin. Microbiol. 49:858-865.
33. Schloss PD, et al. 2009. Introducing mothur: open-source, platformindependent, community-supported software for describing and comparing microbial communities. Appl. Environ. Microbiol. 75:7537-7541.
34. Spencer RC. 1998. The role of antimicrobial agents in the aetiology of Clostridium difficile-associated disease. J. Antimicrob. Chemother. 41(Suppl. C):21-27.
35. Stevenson BS, Eichorst SA, Wertz JT, Schmidt TM, Breznak JA. 2004. New strategies for cultivation and detection of previously uncultured microbes. Appl. Environ. Microbiol. 70:4748-4755.
36. Su WJ, et al. 1987. Role of volatile fatty acids in colonization resistance to Clostridium difficile in gnotobiotic mice. Infect. Immun. 55:1686-1691.
37. Theriot CM, et al. 2011. Cefoperazone-treated mice as an experimental platform to assess differential virulence of Clostridium difficile strains. Gut Microbes 2:326-334.
38. Van der Waaij D, Berghuis JM, Lekkerkerk JE. 1972. Colonization resistance of the digestive tract of mice during systemic antibiotic treatment. J. Hyg. (Lond.) 70:605-610.
39. Van der Waaij D, Berghuis JM, Lekkerkerk-van der Wees JEC. 1971. Colonization resistance of the digestive tract in conventional and antibiotic-treated mice. J. Hyg. (Lond.) 69:405-411.
40. Vollaard EJ, Clasener HA. 1994. Colonization resistance. Antimicrob. Agents Chemother. 38:409-414.
41. Wilson KH. 1993. The microecology of Clostridium difficile. Clin. Infect. Dis. 16(Suppl. 4):S214-S218.
42. Wilson KH, Freter R. 1986. Interaction of Clostridium difficile and Escherichia coli with microfloras in continuous-flow cultures and gnotobiotic mice. Infect. Immun. 54:354-358.
43. Wilson KH, Sheagren JN, Freter R. 1985. Population dynamics of ingested Clostridium difficile in the gastrointestinal tract of the Syrian hamster. J. Infect. Dis. 151:355-361.
44. Wilson KH, Sheagren JN, Freter R, Weatherbee L, Lyerly D. 1986. Gnotobiotic models for study of the microbial ecology of Clostridium difficile and Escherichia coli. J. Infect. Dis. 153:547-551.
45. Wilson KH, Silva J, Fekety FR. 1981. Suppression of Clostridium difficile by normal hamster cecal flora and prevention of antibiotic-associated cecitis. Infect. Immun. 34:626-628.
46. Wong JM, de Souza R, Kendall CW, Emam A, Jenkins DJ. 2006. Colonic health: fermentation and short chain fatty acids. J. Clin. Gastroenterol. 40:235-243.